Where Black-box Drug-Target Interaction Prediction Models Look: Cross-Method Explainability

• URL: http://arxiv.org/abs/2606.14245v1
• Date: Fri, 12 Jun 2026 08:22:43 GMT
• Title: Where Black-box Drug-Target Interaction Prediction Models Look: Cross-Method Explainability
• Abstract summary: We present an interpretability audit of BridgeDPI architecture on three different datasets.<n>We summarize sensitivity and signed effects at raw inputs, at the bridge similarity scaffold, and through the graph convolution.<n>Results show that explainability is most informative when treated as model criticism.
• Score: 4.792942098478821
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Drug-target interaction (DTI) and affinity (DTA) predictors increasingly achieve strong benchmark scores, yet their internal use of sequence, fingerprint, and graph features often remains opaque. We present an interpretability audit of BridgeDPI architecture on three different datasets including Gao, Human, and C.elegans. This study combines gradient-based attributions -- integrated gradients, saliency, layer-wise relevance propagation, SmoothGrad, and SmoothGrad-IG -- with feature-wise occlusion ablation and strict intersection consensus across methods to reduce single-explainer bias. We summarize sensitivity and signed effects at raw inputs, at the bridge similarity scaffold, and through the graph convolution, including edge-level sensitivities and targeted edge removals. The results show that explainability is most informative when treated as model criticism: it reveals modality dominance, padding and special-token artifacts, dataset-dependent cooperative versus suppressive effects across layers, and chemistry-consistent fragment and composition motifs where methods agree. These analyses do not substitute for structural or experimental ground truth, yet they can provide testable hypotheses for downstream validation in computational drug discovery pipelines. More broadly, applying modern XAI to contemporary DTI/DTA models is still an early pass over the rich structure implicit in trained weights and data -- yet even this first layer of scrutiny already helps researchers relate predictions to drug- and target-side representations and to prioritize external validation.

Related papers

• NeuroTrace: Inference Provenance-Based Detection of Adversarial Examples [1.096626056612224]
  We introduce NeuroTrace, a framework for analyzing inference provenance through Inference Provenance Graphs (IPGs)<n>IPGs are heterogeneous graphs that capture both activation behavior and parameter-induced dataflow during a model's forward pass.<n>We evaluate IPG-based detectors for adversarial example detection under intra-attack, multi-attack, and cross-threat transfer settings.
  arXiv  Detail & Related papers  (2026-04-15T22:23:40Z)
• Causal Discovery with Mixed Latent Confounding via Precision Decomposition [0.0]
  Differentiable and score-based DAG learners can misinterpret global latent effects as causal edges, while latent-variable graphical models recover only undirected structure.<n>We propose textscDCL-DECOR, a modular, precision-led pipeline that separates these roles.
  arXiv  Detail & Related papers  (2025-12-31T08:03:41Z)
• Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery [3.1716746406651457]
  This work introduces a sequence-based drug-target interaction framework that integrates structural priors into protein representations.<n>The model achieves state-of-the-art performance on Human and BioSNAP datasets and remains competitive on BindingDB.
  arXiv  Detail & Related papers  (2025-09-18T09:38:46Z)
• Fair Deepfake Detectors Can Generalize [51.21167546843708]
  We show that controlling for confounders (data distribution and model capacity) enables improved generalization via fairness interventions.<n>Motivated by this insight, we propose Demographic Attribute-insensitive Intervention Detection (DAID), a plug-and-play framework composed of: i) Demographic-aware data rebalancing, which employs inverse-propensity weighting and subgroup-wise feature normalization to neutralize distributional biases; and ii) Demographic-agnostic feature aggregation, which uses a novel alignment loss to suppress sensitive-attribute signals.<n>DAID consistently achieves superior performance in both fairness and generalization compared to several state-of-the-art
  arXiv  Detail & Related papers  (2025-07-03T14:10:02Z)
• Robust Molecular Property Prediction via Densifying Scarce Labeled Data [53.24886143129006]
  In drug discovery, compounds most critical for advancing research often lie beyond the training set.<n>We propose a novel bilevel optimization approach that leverages unlabeled data to interpolate between in-distribution (ID) and out-of-distribution (OOD) data.
  arXiv  Detail & Related papers  (2025-06-13T15:27:40Z)
• SOC-DGL: Social Interaction Behavior Inspired Dual Graph Learning Framework for Drug-Target Interaction Identification [6.776003706755337]
  We propose SOC-DGL, which learns global similarity through an affinity-enhanced drug-target graph.<n>It captures higher-order similarity by amplifying the influence of even-hop neighbors using an even-polynomial graph filter based on balance theory.<n> SOC-DGL consistently outperforms existing state-of-the-art methods across both balanced and imbalanced scenarios.
  arXiv  Detail & Related papers  (2025-06-02T08:00:24Z)
• Benchmark on Drug Target Interaction Modeling from a Structure Perspective [48.60648369785105]
  Drug-target interaction prediction is crucial to drug discovery and design. Recent methods, such as those based on graph neural networks (GNNs) and Transformers, demonstrate exceptional performance across various datasets. We conduct a comprehensive survey and benchmark for drug-target interaction modeling from a structure perspective, via integrating tens of explicit (i.e., GNN-based) and implicit (i.e., Transformer-based) structure learning algorithms.
  arXiv  Detail & Related papers  (2024-07-04T16:56:59Z)
• A Generalization Theory of Cross-Modality Distillation with Contrastive Learning [49.35244441141323]
  Cross-modality distillation arises as an important topic for data modalities containing limited knowledge. We formulate a general framework of cross-modality contrastive distillation (CMCD), built upon contrastive learning. Our algorithm outperforms existing algorithms consistently by a margin of 2-3% across diverse modalities and tasks.
  arXiv  Detail & Related papers  (2024-05-06T11:05:13Z)
• Optimizing OOD Detection in Molecular Graphs: A Novel Approach with Diffusion Models [71.39421638547164]
  We propose to detect OOD molecules by adopting an auxiliary diffusion model-based framework, which compares similarities between input molecules and reconstructed graphs. Due to the generative bias towards reconstructing ID training samples, the similarity scores of OOD molecules will be much lower to facilitate detection. Our research pioneers an approach of Prototypical Graph Reconstruction for Molecular OOD Detection, dubbed as PGR-MOOD and hinges on three innovations.
  arXiv  Detail & Related papers  (2024-04-24T03:25:53Z)
• Energy-based Out-of-Distribution Detection for Graph Neural Networks [76.0242218180483]
  We propose a simple, powerful and efficient OOD detection model for GNN-based learning on graphs, which we call GNNSafe. GNNSafe achieves up to $17.0%$ AUROC improvement over state-of-the-arts and it could serve as simple yet strong baselines in such an under-developed area.
  arXiv  Detail & Related papers  (2023-02-06T16:38:43Z)
• Drug-Drug Interaction Prediction with Wasserstein Adversarial Autoencoder-based Knowledge Graph Embeddings [22.562175708415392]
  We propose a new knowledge graph embedding framework for drug-drug interactions. In our framework, the autoencoder is employed to generate high-quality negative samples. The discriminator learns the embeddings of drugs and interactions based on both positive and negative triplets.
  arXiv  Detail & Related papers  (2020-04-15T21:03:29Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.